Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03101371 · ClinicalTrials.gov registry record · Phase 2
Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter Insertion
A Phase 2 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 2
- Development phase
- 99
- Enrollment target
NCT03101371 is a Phase 2 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 99 participants.
The verdict
NCT03101371, a Phase 2 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 99 participants
- Enrollment target
Study Summary
Urinary Tract Infection (UTI) complications following catheter use in surgical patients remains high. Using an aseptic protocol has been shown to drastically reduce UTI incidence by 50%. Reducing UTIs will prevent extended hospital stays, readmission, and antibiotic use associated with this complication and improve cost-effectiveness of care. The investigators hypothesize that they can reduce the incidence of UTIs after catheter placement with the implementation of a Quality Improvement (QI) protocol to prevent excess exposure to the environment exposure of the catheter before, during and after insertion.
Interventions
- DRUG Catheter insertion with Povidone Iodine
- PROCEDURE Standard of care catheter insertion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2017-10-10 |
| Est. Completion | 2019-02-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03101371
The ClinicalTrials.gov registry entry for NCT03101371 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Catheter insertion with Povidone Iodine is the first listed.
NCT03101371 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03101371 about?
NCT03101371 is a clinical study titled "Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter Insertion". Urinary Tract Infection (UTI) complications following catheter use in surgical patients remains high. Using an aseptic protocol has been shown to drastically reduce UTI incidence by 50%. Reducing UTIs will prevent extended hospital stays, readmission, and antibiotic use associated with this complica...
What is the current status of trial NCT03101371?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 99 participants. The study started on 2017-10-10. Estimated completion is 2019-02-15.
What interventions are being tested in trial NCT03101371?
The interventions under investigation include: Catheter insertion with Povidone Iodine (DRUG), Standard of care catheter insertion (PROCEDURE).
Who is sponsoring clinical trial NCT03101371?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.